drugset / Trial / NCT07427446

Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium

NCT07427446

Phase 4 Recruiting 50 enrolled Kasr El Aini Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups. Group DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)

Timeline

Start
2026-02-01
Primary completion
2026-12
Completion
2027-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Comparator Ketamine Small molecule 1 mg/kg Intravenous
Comparator Midazolam Small molecule 0.1 mg/kg Intravenous

Indications